Aegerion CEO on Cholesterol Drug Lomitapide

Oct. 18 (Bloomberg) -- Marc Beer, chief executive officer of Aegerion Pharmaceuticals Inc., talks about the company's lomitapide drug to treat the most life-threatening forms of high cholesterol. A U.S. Food and Drug Administration panel supported the use of the drug. Beer speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
Oil Rises a Second Day Ahead of U.S. Report
58:02 - Oil is gaining ahead of a U.S. Government report on crude supplies. Analysts surveyed say supplies probably fell last week. Bloomberg’s Aaron Clark reports on “Trending Business.” (Source: Bloomberg)
  • Iron Ore Rebound May Spread Across Commodities
  • CapitaLand Profit Rises on Climbing Rents
  • Japan Stocks Attractive on Buyback Prospects